Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
22.89
+0.69 (3.11%)
At close: Oct 27, 2026, 4:00 PM EDT
23.34
+0.45 (1.97%)
After-hours: Oct 27, 2026, 7:50 PM EDT
Tango Therapeutics Employees
Tango Therapeutics had 137 employees as of December 31, 2025. The number of employees decreased by 18 or 11.61% compared to the previous year. That makes Tango Therapeutics the 29,430th largest employer in the world and 3,747th in the United States.
Employees
137
Change (1Y)
-18
Growth (1Y)
-11.61%
Revenue / Employee
$392,781
Profits / Employee
-$903,073
Market Cap
3.86B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 137 | -18 | -11.61% |
| Dec 31, 2024 | 155 | 15 | 10.71% |
| Dec 31, 2023 | 140 | 30 | 27.27% |
| Dec 31, 2022 | 110 | 19 | 20.88% |
| Sep 30, 2022 | 109 | 26 | 31.33% |
| Jun 30, 2022 | 103 | 17 | 19.77% |
| Mar 31, 2022 | 98 | 21 | 27.27% |
| Dec 31, 2021 | 91 | 14 | 18.18% |
| Sep 30, 2021 | 83 | 6 | 7.79% |
| Jun 30, 2021 | 86 | - | - |
| Mar 31, 2021 | 77 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Acadia Pharmaceuticals | 798 |
| AbCellera Biologics | 562 |
| Travere Therapeutics | 497 |
| Xenon Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Relay Therapeutics | 202 |
| Disc Medicine | 165 |
TNGX News
- 1 day ago - Tango Therapeutics added to Analyst Focus List at JPMorgan - TheFly
- 4 days ago - Tango Therapeutics falls -12.6% - TheFly
- 4 days ago - Tango Therapeutics price target raised to $55 from $40 at Stifel - TheFly
- 4 days ago - Tango Therapeutics falls -17.5% - TheFly
- 4 days ago - Tango Therapeutics Transcript: Study result - Transcripts
- 4 days ago - Tango Therapeutics Press release: Study result - Filings
- 4 days ago - Tango Therapeutics Slides: Study result - Filings
- 4 days ago - Tango announces results from obngoing Phase 1/2 study of vopimetostat - TheFly